Select a medication above to begin.
Zelsuvmi
berdazimer topical
Peds Dosing .
- Dosage forms: GEL: 10.3%
molluscum contagiosum
- [1 yo and older]
- Dose: apply qd; Max: 12wk
Contraindications / Cautions .
- hypersensitivity to drug or ingredient
Drug Interactions .
Overview
berdazimer topical
nitric oxide releasing agent topical
-
None
No significant interactions known or found for this drug. Caution always advised with multiple medications.
Adverse Reactions .
Serious Reactions
may occur but none reported
Common Reactions
- allergic contact dermatitis
- skin rxn, local
Safety/Monitoring .
Monitoring Parameters
no routine tests recommended
Pregnancy/Lactation .
Pregnancy
Clinical Summary
weigh risk/benefit during pregnancy; no human data available, though risk of fetal harm not expected based on expected limited systemic absorption
Lactation
Clinical Summary
weigh risk/benefit while breastfeeding; no human data available, though risk of infant harm and adverse effects on milk production not expected based on limited systemic absorption in breastfeeding patients
Pharmacology .
Metabolism: unknown; CYP450: unknown
Excretion: unknown; Half-life: unknown
Subclass: Molluscum Contagiosum Virus
Mechanism of Action
exact mechanism of action unknown
Formulary .
No Formulary Selected
Join Now to View Patient Handouts!
Create a FREE epocrates Online account to access patient medication instructions. Your patients and caregivers will appreciate you printing these friendly handouts, available in English and Spanish. Each handout addresses common concerns such as how to take the medication, and possible side effects.
Current Members: Sign In.
Pill Pictures
Join Now to View Pill Pictures!
Create a FREE epocrates Online account to access full-color images of medications within the drug monograph.
Current Members: Sign In.